GCNN 2027 invites original research contributions across the following tracks. Click any track for full scope, focus areas and submission guidance.
Thrombectomy, mobile stroke units and stroke prevention.
View details 02 · TrackAnti-amyloid therapies, biomarkers and early detection.
View details 03 · TrackBTK inhibitors, remyelination and progressive MS.
View details 04 · TrackAdvanced therapies, DBS, GBA-targeted treatments.
View details 05 · TrackDrug-resistant epilepsy, surgical approaches and genetic epilepsies.
View details 06 · TrackALS, SMA gene therapy and neuropathies.
View details 07 · TrackCGRP antagonists, cluster headache and chronic migraine.
View details 08 · TrackGlioblastoma, brain metastases and novel immunotherapies.
View details 09 · TrackDigital biomarkers, seizure detection and imaging AI.
View details